Diferencias de género en el uso de marcadores tumorales

Analysis of gender perspective in the use of NANDA‐I nursing diagnoses: A systematic review

“…These findings suggest the existence of gender biases in the studies that describe NANDA‐I diagnoses applied to care plans. Previous research has already shown that biases in diagnostic and therapeutic efforts (Moreno Campoy et al, 2015 ; Westergaard et al, 2019 ) can lead health professionals, and nurses in particular, not to respond to the real needs of people and communities (Sutherland et al, 2017 ). Additionally, it is essential to evince and understand differences and gender to take them into account in order to design effective and equitable nursing interventions (Felzmann, 2020 ).…”

“…In the past decade, a large amount of evidence about sex differences in health phenomena (Lin et al, 2019 ; Wenham et al, 2020 ; Zeng et al, 2020 ), differential morbidity (Valls‐Llobet et al, 2008 ) and biases in diagnostic and therapeutic efforts have emerged (Moreno Campoy et al, 2015 ; Westergaard et al, 2019 ). These biases can lead, among others, to non‐effective and non‐equitable responses by health professionals, including nurses, to the needs of individuals and communities (Cascella Carbó & García‐Orellán, 2020 ; Crespí‐Lloréns et al, 2021 ).…”

La inteligencia artificial en los marcadores tumorales

“…PSA o Antígeno prostático específico CYFRA 21, relacionado con el cáncer de pulmón. SCC o Antígeno a carcinoma de células escamosas, capacidad de invasión, el cáncer puede extenderse por el organismo, lo que se conoce como me-tástasis, que es la principal causa de muerte por cáncer (Moreno, 2015).…”